coronary-artery-disease
(2)
James K. Min
James K. Min is the founder and CEO of Cleerly, a Denver-based digital health company using AI to analyze coronary CT scans and detect atherosclerosis long before a heart attack strikes. A board-certified cardiologist who spent two decades in academic medicine, Min left a professorship at Weill Cornell and the directorship of the Dalio Institute of Cardiovascular Imaging to build a company that could deliver personalized, plaque-based heart evaluation at scale. He has authored more than 500 peer-reviewed papers, led landmark cardiac imaging trials, and raised hundreds of millions to push a shift from population-based cardiology toward individualized care.
Barton Wells
Barton Wells is the co-founder, CEO, and CTO of DexaFit Dx, a Palo Alto-based health technology company using AI and full-body DXA scans to detect coronary artery disease, Type 2 diabetes, and other chronic conditions early and non-invasively. A Stanford-trained mathematician and former world-ranked open water marathon swimmer, Wells brings 30+ years of AI, computer vision, and iOS engineering experience - spanning stints at Dropbox and multiple startups - to the challenge of transforming a 7-minute medical scan into a multi-disease risk screening platform for insurers, employers, and individuals.